News | March 06, 2024
Bayer strengthens pharma portfolio with new cardiology drug acoramidis
Acquisition of exclusive commercialization rights for European markets
Acquisition of exclusive commercialization rights for European markets
The talk show will be held monthly via Medanta's YouTube, Facebook and LinkedIn channe
Medway setup a state-of-the-art Heart Institute in Chennai
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
Subscribe To Our Newsletter & Stay Updated
